Investor Presentaiton slide image

Investor Presentaiton

Proven ability to acquire and turn around businesses CFS' acquisition and turnaround of Italian subsidiary was well conceived and executed Demonstrated experience in acquiring and integrating companies CFS Camlin Fine Sciences Acquisition of CFS Europe, Borregaard's Italian subsidiary for EUR1.4mn Acquired in 2011 . ā— At acquisition, Borregaard's Italian subsidiary was engaged in the manufacturing of HQ and Catechol The acquisition gave CFS a significant presence in the European market; helped CFS backward integrate to secure the sources of HQ and Catechol for global operations Company's first international acquisition At acquisition it had a capacity of 6,600MTPA which has been increased to 12,000MTPA through de-bottlenecking and incremental capex Revenues have grown substantially... INR mn 2,289 1,881 1,467 FY12 2,973 2,258 ...with significant improvement in PAT margins 0.4% 0.4% 3.6% 10.8% FY13 FY14 FY15 FY16 FY12 FY13 FY14 FY15 CFS' acquisition, turnaround and integration of CFS Europe is a reflection of the management capabilities of CFS team 12 12 7.9% FY16 CFS Camlin Fine Sciences
View entire presentation